TE_11681
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE order | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 702.18 |
| Counts of samples | TCGA_tumor:622; TCGA_normal:0; GTEx:0 |
| TSS | chr5(-):85638848 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_11681.21 | - | Intergenic | Non-coding | Non-coding | chr5(-):85544273,85544293,85619937,85619995,85620098,85620193,85629688,85629814,85638794,85638849 |
| teRNA_11681.22 | - | Intergenic | Non-coding | Non-coding | chr5(-):85619975,85619995,85620098,85620193,85629688,85629814,85638794,85638849 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
